Alzheimer’s researchers win world’s top brain research prize

pharmafield logo - pharma news

Four world-leading dementia researchers have won a prestigious €1m prize for their contribution to neuroscience.

The 2018 Brain Prize was awarded to Professors John Hardy (London), Bart De Strooper (London and Leuven), Michel Goedert (Cambridge) and Christian Haass (Munich) for their ground-breaking research on the genetic and molecular basis of Alzheimer’s disease.

Jeremy Hughes, Chief Executive at Alzheimer’s Society, said: “As a founder of the UK Dementia Research Institute headed up by Professor De Strooper, and having helped fund Professor Hardy’s early gene discovery work, Alzheimer’s Society is delighted that these researchers have been honoured with the prestigious Brain Prize.
“Since Professor Hardy’s initial genetic discovery, together these researchers have mapped out the key biological pathways in Alzheimer’s disease. Much of the ongoing drug discovery research builds on their pioneering work, looking for ways to stop the build-up of amyloid plaques and the spread of tau tangles, to one day stop Alzheimer’s in its tracks.
“UK scientists being recognised as world leaders in dementia research is a proud achievement – and more importantly, brings us closer to new treatments and cures for the 850,000 people living with dementia.”